Haemonetics Q4 EPS $0.77 Beats $0.70 Estimate, Sales $304.42M Beat $289.64M Estimate

Benzinga · 05/11/2023 10:06
Haemonetics (NYSE:HAE) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.70 by 10 percent. This is a 18.46 percent increase over earnings of $0.65 per share from the same period last year. The company reported quarterly sales of $304.42 million which beat the analyst consensus estimate of $289.64 million by 5.10 percent. This is a 14.87 percent increase over sales of $265.00 million the same period last year.